Why Am I Gaining Weight on Wegovy?

You're still in the titration phase (and the appetite effect hasn't fully arrived yet

Picture this: you're two or three weeks into your first Wegovy pen, you feel vaguely queasy after meals, but the scales have barely moved) or they've crept upward. This is probably the most common scenario our prescribers hear about, and it almost always comes down to where you are in the dosing schedule.

Wegovy starts at 0.25 mg and steps up through 0.5 mg, 1.0 mg, 1.7 mg and eventually 2.4 mg, with roughly four weeks at each level. At the lower doses, GLP-1 receptor activation is real but modest. The appetite suppression that the medicine is best known for tends to become noticeably stronger at 1.0 mg and above. In the early weeks, some people find nausea reduces their appetite at dinner but leaves them eating more at breakfast to compensate, and the net calorie balance doesn't change much. The NHS semaglutide medicines page notes that nausea is among the most common early side effects, precisely because the dose is still building. If your weight is drifting up at 0.25 mg or 0.5 mg, the most useful thing to do is track your intake honestly and report it at your next clinical review. It's a dosing-phase issue, not a sign the treatment isn't going to work.

The STEP 1 trial, published in the New England Journal of Medicine, reported an average weight loss of around 15% at 68 weeks on 2.4 mg, but that average conceals a lot of variation in the early months. Weight gain in weeks one to eight is not unusual.

Nausea is changing what and when you eat

This one catches people off guard. Semaglutide slows gastric emptying quite significantly, especially at higher doses. Food stays in the stomach longer, which means some foods that you tolerated easily before (high-fibre vegetables, red meat, anything fried) can now trigger nausea or discomfort. The natural response is to reach for foods that feel manageable: crackers, white toast, full-fat yoghurt, juice. These tend to be calorie-dense and low in protein.

If this pattern sounds familiar, you're not eating badly or failing. You're responding to an uncomfortable side effect the way any sensible person would. The practical fix is to work towards higher-protein, lower-fat choices that are still gentle on the stomach (plain chicken, eggs, low-fat dairy, soft fish) while keeping portions small and eating slowly. Protein matters more than usual on GLP-1 treatment because rapid weight loss can include lean mass if dietary protein is insufficient. You'll find more background on managing intake during treatment on our Wegovy treatment guide.

If nausea is severe or persistent rather than mild and transient, that's a conversation for your prescriber rather than a dietary workaround. Adjusting the titration pace is a legitimate clinical option.

Plateau, water retention, or a true gain, how to tell

The scales measure everything: fat, muscle, bone, water, glycogen stores, the contents of your digestive tract at that moment. On Wegovy, water retention can fluctuate meaningfully, particularly around dose changes. A 1–2 kg rise after a new pen isn't unusual and can resolve within a week or two as your body adjusts.

A true weight gain (sustained upward movement over three or four consecutive weeks) does need attention. The most common causes beyond the ones above are: alcohol intake (easy to underestimate, high in calories, and not suppressed by semaglutide in the way food appetite is), medication changes (steroids, some antidepressants and antipsychotics are associated with weight gain and can work against semaglutide's effects), and thyroid changes that go undetected. A prescriber review should rule these out before concluding the medicine isn't working.

If you are wondering whether cost is a reason people pause or skip doses (which can trigger appetite rebound between injections) it's worth reading the Wegovy cost breakdown to understand what an all-in private prescription actually covers. Skipping doses to save money is one of the more reliable ways to see the scales go up.

The broader question of why weight can increase during or after treatment is explored in our guide to weight gain on Wegovy, which covers both on-treatment and post-treatment patterns in more depth. If you are specifically finding that you are gaining weight while still on Wegovy, or are concerned about gaining weight after finishing a course of Wegovy, both of those situations have their own dedicated pages with more targeted guidance.

When to speak to your prescriber

Most weight fluctuations on Wegovy resolve with time or a small adjustment to habits. But some situations need a clinical conversation sooner rather than later. Speak to a prescriber if your weight has been rising consistently for more than three to four weeks, if you've had to reduce or skip doses because of side effects, if you're experiencing symptoms that make eating difficult to manage, or if you're approaching the end of a dose phase without meaningful progress.

At nume, every repeat order goes through a same-day review by a GPhC-registered prescriber, not a checkbox system, an actual clinical read. If the weight trend isn't right, that review is where it gets caught. If you've stopped Wegovy and are seeing weight come back, the dynamics are different; gaining weight after stopping Wegovy follows its own pattern and is worth understanding separately.

The MHRA's guidance on GLP-1 medicines is clear that these are not assessed for quick or cosmetic results, they work best as part of a sustained, clinically supervised programme. If something isn't working, the answer is to talk to a prescriber, not to try a higher dose without guidance or switch products without review.